Dissertation > Excellent graduate degree dissertation topics show

Effect of CYP3A5, CYP2C19 Gene Polymorphism on Pharmacokinetic Characteristics of Voriconazole in Chinese Volunteers

Author: HuangFei
Tutor: XiongYuQing
School: Nanchang University
Course: Pharmacology
Keywords: CYP3A5 CYP2C19 voriconazole pharmacokinetics gene polymorphism
CLC: R96
Type: Master's thesis
Year: 2011
Downloads: 63
Quote: 0
Read: Download Dissertation

Abstract


Background:Voriconazole is a new second-generation triazole antifungal agent, which undergoes a metabolism involving cytochrome P450(CYP) enzyme isoforms CYP2C19 and CYP3A4. However, Chinese people possess a very low frequency of polymorphism in CYP3A4. CYP3A4 and CYP3A5 often affects same substrate drug’s pharmacokinetics together. Studies have shown that CYP3A5 and CYP2C19 do exist gene polymorphism and play important roles in many drugs’ pharmacokinetics. Therefore, it is important to study the effect of CYP3A5 and CYP2C19 gene polymorphism on the pharmacokinetic of voriconazole to the clinical application of it.Objectives:To study the effect of CYP3A5, CYP2C19 gene polymorphism in Chinese people on the pharmacokinetic characteristics of voriconazole and instruct the reasonable clinical application of voriconazole by the feature of gene polymorphism.Methods:1 An LC-MS method for the determination of voriconazole in plasma was established and successfully applied to the pharmacokinetic study of voriconazole in Chinese people.2 20 volunteers were choosed according to pharmacokinetic standard. Then genotyping of CYP3A5 and CYP2C19 was made with the method of polymerase chain reaction-restriction fragment length polymorphism targeted at healthy volunteers’blood (wild type, heterozygous and homozygous).3 After a single oral dose 200 mg voriconazole tablets,5mL blood plasma were collected to the heparinized tubes at the lines of 0.0、0.25、0.5、0.75、1.0、1.5 2.0、3.0、4.0、6.0、8.0、12.0、24.0、36.0h. The blood plasma was obtained by entrifugalization and the concentration of voriconazole plasma was determinatied using the above LC-MS method.4 According to the measured data of voriconazole concentration of plasma, the main pharmacokinetic parameters of voriconazole were calculated by DAS 2.1 software, analysed and compared the voriconazole human pharmacokinetic characteristics of the wild type, heterozygous and homozygous by SPSS 17.0.Results:1 The establishment of determination of voriconazole in plasm with LC-MS has good sensitivity and specificity and is consistent with demanding of analysis of biology sample.2 Genotyping of 20 healthy volunteers showed that there are 3 people carrying CYP3A5*1/*1、5 people carrying CYP3A5*1/*3 and 12 people carrying CYP3A5*3/*3; there are 7 people carrying CYP2C19*1/*1、7 people carrying heterozygous (CYP2C19*1/*3、CYP2C19*1/*2) and 5 people carrying homozygous (CYP2C19*2/*2、CYP2C19*2/*3、CYP2C19*3/*3)3 Voriconazole pharmacokinetic characteristics in Chinses people by binding CYP3A5 and CYP2C19 was studied. It is found that CYP3A5 gene polymorphism do not affect any pharmacokinetic parameters of voriconazole (P>0.05), cueing that CYP3A5 gene polymorphism do not affect the pharmacokinetic parameters of voriconazole. It is found that the main pharmacokinetic parameters of AUC0-36、AUC0-x of CYP2C19 homozygous was notable higher than wild type and the heterozygous (P<0.05), the parameter of CL/F was notable lower than the wild type (P<0.05) at dose of 200mg, but the parameters of T1/2, Cmax had no statistical differences (P>0.05) cueing that CYP2C19 gene polymorphism do affect the pharmacokinetic parameters of voriconazole.Conclusions:CYP2C19 gene polymorphism do affect the pharmacokinetic parameters of voriconazole and CYP3A5 gene polymorphism do not affect the pharmacokinetic parameters of voriconazole. We should base on CYP2C19 gene polymorphism to guide the reasonable application of voriconazole during the clinical applications.

Related Dissertations

  1. CYP2C19 Gene Polymorphism in Patients with Ischemic Cerebrovascular,R743
  2. Study on the Pharmacokinetics of Xiaoaiping and Chlorogenic Acid in Rats and the Quality Standard of Xiaoaiping Preparations,R285
  3. The Relationship of Polymorphisms of Methionine Synthase Reductase(MTRR) Gene and Plasma Homocysteine Levels with Myocardial Infarction,R542.22
  4. Preparation and Quality Assessment of Indapamide Micro-porous Osmotic Pump Tablet,TQ463
  5. Pharmacokinetics of Progesterone Cream in Beagle Dogs Determined with LC-MS/MS,R96
  6. Association of Interleukin-6 Gene Polymorphisms with Susceptibility to Coronary Heart Disease in Asian Populations: a Meta-analysis,R541.4
  7. Pharmacokinetics of Gelatin Sponge Particles in a Rabbit VX2 Liver Tumor Model of Hepatic Arterial Embolization,R735.7
  8. Study of the Expression of Toll-like Receptor 2, 4mRNA and Polymorphisms of Patients with Leprosy,R755
  9. Bevacizumab -PLGA Microspheres intravitreal injection in rabbit eyes pharmacokinetics and distribution of drugs,R96
  10. MDR1 and CYP3A gene polymorphisms on digoxin plasma concentrations of,R96
  11. Application IP-RP-HPLC method study of creatine phosphate in mice pharmacokinetics and metabolic disposition,R96
  12. Building of Approved Veterinry Drug Database and Analysis of Retrospective Enrofloxacin Pharmacokintic Data,S851.66
  13. SLC2A9 gene eighth exon 137A / G polymorphism and diabetic patients with hyperuricemia relationship,R587.1
  14. The Expression of DNA Adducts dA in Chronic Atrophis Gastritis, Precancerous Lesions and Gastric Cancer and the Relationship with the CYP2E1 Gene Polymorphism,R735.2
  15. The Influence of Innate Immune Molecules and Cells in the Pathogenesis of Autoimmune Disease in Central Nervous System,R392
  16. Study on the Two Different Routes of Absorbing APIC in Rats and Enteric-coated APIC Solid Dispersion,R965
  17. Application of HPLC-MS/MS in Clinical Pharmacokinetics Study of Cyclobenzaprine and Leitosteine,R96
  18. Research of Casein Solid Self-emulsifying Drug Delivery Systems (SEDDS) for Improving Oral Bioavailability,R96
  19. Lotus alkaloids fluorescence assay and neferine influence the pharmacokinetics of amiodarone,R965
  20. Bicalutamide enantiomers of chiral and pharmacokinetic studies,R96
  21. The Correlation Research between the Gene Polymorphisms of Five CYP450 Isoforms of Enzymes and the Differences of Metabolic Ratio of Cocktail Probes,R969.1

CLC: > Medicine, health > Pharmacy > Pharmacology
© 2012 www.DissertationTopic.Net  Mobile